⌘K
Loading ticker…
Quest Diagnostics Inc. · Healthcare · Healthcare
As of 2026-06-26, Quest Diagnostics Inc. (DGX) has a 3-month relative strength percentile of 52 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.2%, relative volume 1.54×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
52 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
DGX is in a stage 2 uptrend, week 1. Currently in a 82-day base; basing ADR 2.2% (broad 2.0%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 7.2% / 10.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
DGX is held by 18 ETFs as of Mar 2026. Top owner: VTI at 0.03% weight, $684M notional. Top 3 carry $1.7B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.03% | $684M |
| VOOVanguard S&P 500 ETF | 0.04% | $548M |
| VOVanguard Mid-Cap ETF | 0.23% | $465M |
| IVViShares Core S&P 500 ETF | 0.04% | $277M |
| SPYState Street SPDR S&P 500 ETF | 0.04% | $250M |
| VTVVanguard Value ETF | 0.09% | $199M |
| XLVState Street Health Care Select Sector SPDR ETF | 0.41% | $157M |
| IWRiShares Russell Midcap ETF | 0.17% | $84M |
| IWDiShares Russell 1000 Value ETF | 0.07% | $50M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.04% | $45M |
Showing 10 of 18 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DGX Jan avg: 0.99% median: 1.35% win: 50% σ: 8.07% n: 4 2022-04-12 → 2026-05-29 | DGX Feb avg: 2.44% median: 1.63% win: 50% σ: 9.01% n: 4 2022-04-12 → 2026-05-29 | DGX Mar avg: -0.21% median: 0.06% win: 50% σ: 6.04% n: 4 2022-04-12 → 2026-05-29 | DGX Apr avg: 0.75% median: -0.91% win: 40% σ: 3.58% n: 5 2022-04-12 → 2026-05-29 | DGX May avg: 0.26% median: 0.36% win: 60% σ: 3.98% n: 5 2022-04-12 → 2026-05-29 | DGX Jun avg: 0.08% median: 0.02% win: 50% σ: 5.60% n: 4 2022-04-12 → 2026-05-29 (current) | DGX Jul avg: -0.99% median: -0.55% win: 50% σ: 5.16% n: 4 2022-04-12 → 2026-05-29 | DGX Aug avg: 1.96% median: 2.88% win: 50% σ: 8.92% n: 4 2022-04-12 → 2026-05-29 | DGX Sep avg: -1.40% median: -1.59% win: 25% σ: 5.02% n: 4 2022-04-12 → 2026-05-29 | DGX Oct avg: 3.98% median: 3.25% win: 50% σ: 10.54% n: 4 2022-04-12 → 2026-05-29 | DGX Nov avg: 5.94% median: 5.59% win: 100% σ: 1.09% n: 4 2022-04-12 → 2026-05-29 | DGX Dec avg: -3.00% median: -3.39% win: 50% σ: 5.61% n: 4 2022-04-12 → 2026-05-29 |